Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
Central Nervous System Abnormalities in Lyme Neuroborreliosis
Neurol 41:1571-1582, Halperin,J.J.,et al, 1991
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Neurol 97:e1367-e1381, Gaig, C.,et al, 2021
Multiple Sclerosis with and without CSF Bands:Clinically Indistinguishable but Immunogenetically Distinct
Neurol 67:1062-1064, Imrell,K.,et al, 2006
Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998
A Long-Term Prospective Study of Optic Neuritis:Evaluation of Risk Factors
Ann Neurol 27:386-393, Sandberg-Wollheim,M.,et al, 1990
Narcolepsy & Immunity
BMJ 292:359-360, Parkes,J.D.,et al, 1986
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Juvenile Dermatomyositis and Other Idiopathic Inflammatory Myopathies of Childhood
Lancet 371:2201-2212, Feldman,B.M.,et al., 2008
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Narcolepsy Associated with Lesions of the Diencephalon
Neurol 39:1505-1508, Aldrich,M.S.&Naylor,M.W., 1989
Cellular Immunity In Guamanians with Amyotrophic Lateral Sclerosis & Parkinsonism-Dementia
NEJM 299:680-685, Hoffman,P.M.,et al, 1978
Cogan's Syndrome & HLA BW17
NEJM 295:1262, DelCarpio,J.,et al, 1976